Skip to main content
Clinical Trials/IRCT20111119008129N13
IRCT20111119008129N13
Completed
Phase 3

Evaluation of the effects of resveratrol consumption on inflammatory and biochemical parameters of patients with Covid ??

Boushehr University of Medical Sciences0 sites140 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Covid-19.
Sponsor
Boushehr University of Medical Sciences
Enrollment
140
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Boushehr University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Female and Male with the age between 18 to 55 years
  • Long involvement approved by city scan
  • Admitted to the hospital with Fever( \= 38 C°)
  • The breath rate \= 24/min, or coughing ( before the 8th day of the disease )
  • Infection with covid 19, approved by PCR

Exclusion Criteria

  • Pregnant women
  • Patients with kidney Disease,
  • Patients with hypercalcemia and hypercalciuria
  • Patients with any type of allergic diseases
  • Having any kind of disease by which the patients can't have a proper participation
  • Inability to behave properly( having Mental problem
  • Auto immune diseases ( having MS, Lupus ...)
  • Kidney Failure, Hepatitis B and C
  • Patients with acute covid 19 symptoms

Outcomes

Primary Outcomes

Not specified

Similar Trials